35.87
前日終値:
$35.51
開ける:
$35.65
24時間の取引高:
3.21M
Relative Volume:
0.72
時価総額:
$14.15B
収益:
$2.26B
当期純損益:
$1.09B
株価収益率:
15.31
EPS:
2.3431
ネットキャッシュフロー:
$2.70B
1週間 パフォーマンス:
-0.88%
1か月 パフォーマンス:
+7.43%
6か月 パフォーマンス:
+36.91%
1年 パフォーマンス:
+39.95%
Royalty Pharma Plc Stock (RPRX) Company Profile
名前
Royalty Pharma Plc
セクター
電話
(212) 883-0200
住所
110 EAST 59TH STREET, NEW YORK, NY
RPRX を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
RPRX
Royalty Pharma Plc
|
35.87 | 14.15B | 2.26B | 1.09B | 2.70B | 2.3431 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
478.96 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
552.58 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
320.87 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
555.19 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
255.69 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-05-16 | 開始されました | Morgan Stanley | Overweight |
2024-06-03 | ダウングレード | UBS | Buy → Neutral |
2022-06-14 | 再開されました | UBS | Buy |
2022-05-13 | 開始されました | Scotiabank | Sector Outperform |
2022-04-27 | 開始されました | Goldman | Buy |
2022-04-14 | アップグレード | JP Morgan | Neutral → Overweight |
2022-04-06 | 再開されました | Morgan Stanley | Overweight |
2021-10-29 | アップグレード | Citigroup | Neutral → Buy |
2021-07-30 | 開始されました | Tigress Financial | Buy |
2020-11-09 | アップグレード | UBS | Neutral → Buy |
2020-07-14 | 開始されました | Evercore ISI | In-line |
2020-07-13 | 開始されました | BofA Securities | Buy |
2020-07-13 | 開始されました | Citigroup | Neutral |
2020-07-13 | 開始されました | Cowen | Outperform |
2020-07-13 | 開始されました | Goldman | Neutral |
2020-07-13 | 開始されました | JP Morgan | Neutral |
2020-07-13 | 開始されました | Morgan Stanley | Equal-Weight |
2020-07-13 | 開始されました | SunTrust | Buy |
2020-07-13 | 開始されました | UBS | Neutral |
すべてを表示
Royalty Pharma Plc (RPRX) 最新ニュース
SG Americas Securities LLC Makes New Investment in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) On An Uptrend: Could Fundamentals Be Driving The Stock? - simplywall.st
Royalty Pharma PLC (NASDAQ:RPRX) Shares Sold by Bank Pictet & Cie Europe AG - MarketBeat
Wealth Enhancement Advisory Services LLC Takes Position in Royalty Pharma plc (NASDAQ:RPRX) - Defense World
Wealth Enhancement Advisory Services LLC Acquires New Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
(RPRX) Trading Signals - news.stocktradersdaily.com
Short Interest in Royalty Pharma plc (NASDAQ:RPRX) Expands By 39.9% - MarketBeat
53,487 Shares in Royalty Pharma plc (NASDAQ:RPRX) Bought by SG Americas Securities LLC - Defense World
Merit Financial Group LLC Makes New $252,000 Investment in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
GAMMA Investing LLC Increases Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma (NASDAQ:RPRX) Reaches New 12-Month HighWhat's Next? - MarketBeat
Pallas Capital Advisors LLC Has $3.13 Million Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma stock hits 52-week high at $34.33 amid robust growth - Investing.com
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Handelsbanken Fonder AB - MarketBeat
Wedge Capital Management L L P NC Buys Shares of 1,014,799 Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma at Goldman Sachs Conference: Strategic Growth Insights By Investing.com - Investing.com Nigeria
RPRX Q1 Earnings Call: Flat Revenue, Portfolio Expansion, and Capital Return Initiatives - Yahoo Finance
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Ameriprise Financial Inc. - MarketBeat
Royalty Pharma to Present at the Goldman Sachs 46th Annual Global Healthcare Conference - The Manila Times
Royalty Pharma to Share Strategic Updates at Goldman Sachs Healthcare Conference 2025 - Stock Titan
(RPRX) Technical Data - news.stocktradersdaily.com
Mackenzie Financial Corp Increases Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
California State Teachers Retirement System Grows Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
33,531 Shares in Royalty Pharma plc (NASDAQ:RPRX) Acquired by 111 Capital - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Stock Position Trimmed by Tidal Investments LLC - MarketBeat
150,344 Shares in Royalty Pharma plc (NASDAQ:RPRX) Acquired by Lansforsakringar Fondforvaltning AB publ - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 350,315 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
GF Fund Management CO. LTD. Invests $238,000 in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Squarepoint Ops LLC Lowers Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Stock Holdings Lifted by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - MarketBeat
Janus Henderson Group PLC Decreases Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
University of Texas Texas AM Investment Management Co. Purchases New Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
USS Investment Management Ltd Has $4.14 Million Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Quantinno Capital Management LP Grows Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
State of Wyoming Has $385,000 Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Captrust Financial Advisors Lowers Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Two Sigma Investments LP Has $61.74 Million Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Worldquant Millennium Advisors LLC Has $15.57 Million Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma Plc (RPRX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):